Recommendations for Dose Adjustments of Infliximab in Crohn's Disease Patients with Higher Clearance

被引：0
|
作者：
Andersson, Helena [1 ,2 ]
Eser, Akexander [3 ]
Huisinga, Wilhelm [4 ]
Reinisch, Walter [3 ]
Kloft, Charlotte [1 ]
机构：
[1] Free Univ Berlin, Inst Pharm, Dept Clin Pharm & Biochem, Berlin, Germany
[2] Grad Res Training Program PharMetrX, Berlin, Germany
[3] Med Univ Vienna, Dept Gastroenterol & Hepatol, Vienna, Austria
[4] Univ Potsdam, Inst Math, Potsdam, Germany
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
M-045
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [1] Infliximab dose intensification in patients with Crohn's disease
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4 (11): : 588 - 589
  • [2] Dose Intensification of Infliximab in Crohn's Disease
    Rodemann, Joseph
    Regueiro, Miguel
    [J]. PRACTICAL GASTROENTEROLOGY, 2008, 32 (12) : 8 - 14
  • [3] Infliximab dose intensification in Crohn's disease
    Regueiro, Miguel
    Siemanowski, Benjamin
    Kip, Kevin E.
    Plevy, Scott
    [J]. INFLAMMATORY BOWEL DISEASES, 2007, 13 (09) : 1093 - 1099
  • [4] Durability of Infliximab Dose Intensification in Crohn’s Disease
    Kirk K. Lin
    Fernando Velayos
    Elena Fisher
    Jonathan P. Terdiman
    [J]. Digestive Diseases and Sciences, 2012, 57 : 1013 - 1019
  • [5] Durability of Infliximab Dose Intensification in Crohn's Disease
    Lin, Kirk K.
    Velayos, Fernando
    Fisher, Elena
    Terdiman, Jonathan P.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (04) : 1013 - 1019
  • [6] Evidence of infliximab dose stability in Crohn's disease
    Cohen, R
    Farr, C
    Ziskind, M
    Tandon, N
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S228 - S228
  • [7] Durability of Infliximab Dose Intensification in Crohn's Disease
    Lin, Kirk
    Terdiman, Jonathan E.
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S695 - S695
  • [8] Population pharmacokinetics of single dose infliximab in patients with Crohn's disease.
    Fasanmade, AA
    Zhu, YW
    Wagner, C
    Pendley, C
    Davis, HM
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P66 - P66
  • [9] Outcomes after dose escalation of infliximab in Japanese patients with Crohn's disease
    Sako, M.
    Kawaguchi, T.
    Hirayama, A.
    Fukushi, G.
    Hayama, K.
    Fujiwara, T.
    Yoshimura, N.
    Takazoe, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S231 - S231
  • [10] Higher Rates of Dose Optimisation for Infliximab Responders in Ulcerative Colitis than in Crohn's disease
    O'Donnell, Sarah
    Stempak, Joanne M.
    Steinhart, A. Hillary
    Silverberg, Mark S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 (10): : 830 - 836
12345